153
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up

, , , , , , , , , & show all
Pages 1026-1027 | Received 18 Apr 2020, Accepted 04 Aug 2020, Published online: 16 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sinan Mersin, Fatih Gülük, Emirhan Gülcan & Ahmet Emre Eşkazan. (2023) Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults. Expert Opinion on Pharmacotherapy 24:15, pages 1703-1713.
Read now
Massimo Breccia, Emilia Scalzulli, Sara Pepe, Gioia Colafigli, Maria Laura Bisegna, Marcello Capriata & Maurizio Martelli. (2022) Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients. Expert Review of Hematology 15:1, pages 25-32.
Read now
Massimo Breccia, Fabio Efficace, Gioia Colafigli, Emilia Scalzulli, Alessio Di Prima, Maurizio Martelli & Robin Foà. (2020) Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice. Expert Review of Hematology 13:12, pages 1311-1318.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.